Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
1,043
Total Claims
$108K
Drug Cost
194
Beneficiaries
$557
Cost/Patient
Risk Score Breakdown 15/100
Score components are additive. Read full methodology
Peer Comparison vs. 1,080 Hospice and Palliative Care providers
+60%
Opioid rate vs peers
53.2% vs 33.2% avg
-9%
Cost per patient vs peers
$557 vs $611 avg
+78%
Brand preference vs peers
12.0% vs 6.7% avg
Opioid Prescribing
53.2%
Opioid Rate
555
Opioid Claims
$61K
Opioid Cost
51.7%
Long-Acting Rate
This provider's opioid prescribing rate of 53.2% is above the 20% threshold that CMS considers elevated.
Brand vs Generic
Brand: 125 claims · $62K
Generic: 918 claims · $46K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Fentanyl | 129 | $23K |
| Lipase/Protease/Amylase | 15 | $19K |
| Oxycodone Myristate | 14 | $12K |
| Buprenorphine | 33 | $11K |
| Naloxegol Oxalate | 12 | $6,470 |
| Oxycodone Hcl | 94 | $2,365 |
| Oxycodone Hcl/Acetaminophen | 71 | $2,275 |
| Pregabalin | 58 | $2,247 |
| Hydromorphone Hcl | 54 | $1,986 |
| Gabapentin | 56 | $1,445 |
| Methadone Hcl | 76 | $1,420 |
| Morphine Sulfate | 30 | $1,088 |
| Prochlorperazine Maleate | 17 | $719 |
| Ondansetron | 19 | $661 |
| Morphine Sulfate | 18 | $635 |
Prescribing Profile
21
Unique Drugs
15.0
Anomaly Score
Patient Profile
71
Avg Age
60%
Female
3.40
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About